APA (7th ed.) Citation
(2026). Sunvozertinib in EGFR Exon 20 Insertion NSCLC: Approved but Not Available – Practical Dose Selection Considerations and Real-World Access Challenges. Lung Cancer: Targets and Therapy.
Chicago Style (17th ed.) Citation
"Sunvozertinib in EGFR Exon 20 Insertion NSCLC: Approved but Not Available – Practical Dose Selection Considerations and Real-World Access Challenges." Lung Cancer: Targets and Therapy 2026.
MLA (9th ed.) Citation
"Sunvozertinib in EGFR Exon 20 Insertion NSCLC: Approved but Not Available – Practical Dose Selection Considerations and Real-World Access Challenges." Lung Cancer: Targets and Therapy, 2026.
Warning: These citations may not always be 100% accurate.